Reproduction and Fertility is an open-access, peer-reviewed journal
Page URL:
CONTENTS Issue #492
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

How good a solution is single embryo transfer (SET) for fertility patients?
26 January 2009 - by Norbert Gleicher
On the European side of the Atlantic single embryo transfer (SET) is increasingly becoming standard practice. As a consequence of legislation, as in Belgium, of professional dogma, as in most Scandinavian countries, or the product of the regulatory prowess of the Human Fertilisation and Embryology Authority (HFEA), as in the... [Read More]
Elective single embryo transfer (eSET) policy implementation to all UK IVF centres from 2009: Reality or Myth?
26 January 2009 - by Shantal Rajah
Elective single embryo transfer (eSET) policy implementation has raised many issues among patients, IVF experts and fund holders. The main concern in relation to this policy is that we do not know how much, and by what percentage, it will reduce the pregnancy rate in our patients. The policy says... [Read More]
The debate about single embryo transfer isn't NICE
26 January 2009 - by Sandy Starr
This month sees the coming into force of new regulations by the UK's Human Fertilisation and Embryology Authority (HFEA), which seek to ensure that elective single embryo transfer (eSET) for women under 40 becomes standard practice in IVF treatment in the UK. Under these regulations, public and private fertility clinics... [Read More]
Is your DNA public property? Warning over lack of genetic privacy in US
25 January 2009 - by Dr Rebecca Robey
Thousands of people every year in the US are having their DNA collected and analysed without their knowledge or consent, according to a report by the weekly science magazine, New Scientist. In an article published in the 24 January issue, the journal revealed their investigation into the... [Read More]
EGAPP releases three new recommendations on genetic testing
25 January 2009 - by Dr Will Fletcher
The US Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group (EWG) has released evidence-based recommendations on the validity and utility of three genetic tests currently being used in clinical practice. The new recommendations were made regarding three tumour genetic profiling tests used in breast... [Read More]
Charity calls for confidential breast cancer information to be shared
26 January 2009 - by Sarah Pritchard
A professor conducting research on behalf of Genesis Appeal, the UK's only charity dedicated to the prevention of breast cancer, has called for doctors to be allowed to inform patients that they are carriers of mutations in the BRCA1 or BRCA2 genes, thus making them aware of... [Read More]
Gene mutation common in South Asians can increase risk of heart disease
26 January 2009 - by Dr Nadeem Shaikh
A new multinational study, published in Nature Genetics has identified a gene mutation which may dramatically increase the risk of developing certain types of heart disease for 60 million South Asians. The study - led by Kumarasamy Thangaraj of the Centre for Cellular and Molecular Biology in Hyderabad... [Read More]
Can river pollution cause male infertility?
26 January 2009 - by Dr Charlotte Maden
Pollutants have been found in British rivers that could account for the decreasing male fertility in the country. A study that examined wild male fish in rivers developing female reproductive organs found a link between this and the presence of 'anti-androgens' in the water. These drugs, used... [Read More]
FDA approves embryonic stem cell therapy for clinical trials
26 January 2009 - by Antony Starza-Allen
The US Food and Drug Administration (FDA) has allowed the biotech firm, Geron, to begin clinical trials using embryonic stem (ES) cells to help treat spinal cord injury sufferers who have become paralysed from the chest down. The product known as GRNOPC1 will be tested for its... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX